Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency
Open Access
- 1 September 2013
- journal article
- research article
- Published by Taylor & Francis in mAbs
- Vol. 5 (5) , 678-689
Abstract
Amyloid β (Aβ) immunotherapy is considered a promising approach to Alzheimer disease treatment. In contrast to the use of complete antibodies, administration of single-chain variable fragments (scFv) has not been associated with either meningoencephalitis or cerebral hemorrhage. ScFv-h3D6 is known to preclude cytotoxicity of the Aβ1–42 peptide by removing its oligomers from the amyloid pathway. As is the case for other scFv molecules, the recombinant production of scFv-h3D6 is limited by its folding and stability properties. Here, we show that its urea-induced unfolding pathway is characterized by the presence of an intermediate state composed of the unfolded VL domain and the folded VH domain, which suggests the VL domain as a target for thermodynamic stability redesign. The modeling of the 3D structure revealed that the VL domain, located at the C-terminal of the molecule, was ending before its latest β-strand was completed. Three elongation mutants, beyond VL-K107, showed increased thermodynamic stability and lower aggregation tendency, as determined from urea denaturation experiments and Fourier-transform infrared spectroscopy, respectively. Because the mutants maintained the capability of removing Aβ-oligomers from the amyloid pathway, we expect these traits to increase the half-life of scFv-h3D6 in vivo and, consequently, to decrease the effective doses. Our results led to the improvement of a potential Alzheimer disease treatment and may be extrapolated to other class-I scFv molecules of therapeutic interest.Keywords
This publication has 32 references indexed in Scilit:
- Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomersProtein Engineering, Design and Selection, 2008
- Amyloid-β immunisation for Alzheimer's diseaseThe Lancet Neurology, 2008
- Altered Dimer Interface Decreases Stability in an Amyloidogenic ProteinJournal of Biological Chemistry, 2008
- Folding of an antibody variable domain in two functional conformations in vitro: calorimetric and spectroscopic study of the anti-ferritin antibody VL domainProtein Engineering, Design and Selection, 2007
- ProSA-web: interactive web service for the recognition of errors in three-dimensional structures of proteinsNucleic Acids Research, 2007
- Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse modelBiochemical and Biophysical Research Communications, 2006
- Stability engineering of antibody single-chain Fv fragmentsJournal of Molecular Biology, 2001
- Removal of the conserved disulfide bridges from the scfv fragment of an antibody: effects on folding kinetics and aggregationJournal of Molecular Biology, 1999
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- Basic local alignment search toolJournal of Molecular Biology, 1990